ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KMK Kromek Group Plc

6.85
0.00 (0.00%)
23 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.85 6.50 7.20 6.85 6.59 6.85 179,458 08:00:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -6.72 41.12M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.85p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.25p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £41.12 million. Kromek has a price to earnings ratio (PE ratio) of -6.72.

Kromek Share Discussion Threads

Showing 5451 to 5473 of 7275 messages
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older
DateSubjectAuthorDiscuss
14/10/2021
12:46
no news then on the covid sniffer thingamajig.

funny that innit.

what about those trial results....where are they

anyone know?

all imo. dyor.
qp

quepassa
12/10/2021
09:45
“Investing in technology is the best way to defeat the next pandemic” Jeremy Hunt Chair of Health Select committee report on handling of pandemic.
aqc888
10/10/2021
14:09
kromek youtube northern business leaders

Search on google

strategicinvestor2
10/10/2021
14:07
Very interesting Northern Business Leaders update on Utube….
strategicinvestor2
08/10/2021
08:59
Topped up here yesterday. All signs looking quite positive and hoping for an advance towards 20p (and beyond!).
fez77
08/10/2021
08:42
Good news on cancer detection and also positive broker update of current value in excess of 50p. Hopefully news flow in coming months pushes us higher.
strategicinvestor2
07/10/2021
14:34
We are very excited to present, for the first time, a new concept for a low-dose Molecular Breast Imaging (MBI) gamma camera. The idea of the new disruptive design has been developed in collaboration with a world-renowned image reconstruction group from University College London led by Prof. Brian Hutton. This novel MBI technology is particularly effective for detecting breast cancer in women with dense breast tissue, where MBI has been shown to have high sensitivity and specificity. As a result, the cancer detection rate is significantly improved when used in the clinical practice alongside mammography and MRI. Our innovation is addressing the two main shortcomings of current MBI technology – higher effective patient dose and much longer screening time. The goal of our technology roadmap is to reduce the effective patient dose to the mammography level and to shorten the measurement time considerably.

This new technology is revealing the full potential of CZT detectors. Our development is based on Kromek’s 3D position sensitive CZT detectors, and we are confident this will unveil the new capabilities and advantages of CZT cameras not only in breast imaging but in other applications in gamma ray medical imaging.

Current progress will be reported in three talks during the IEEE NSS MIC Virtual Event:

RTSD oral talk by Dr. Alexander Cherlin (Kromek) on 20 October – (#1055) “A new concept for a low-dose stationary tomographic Molecular Breast Imaging camera using 3D position sensitive CZT detectors”
MIC oral talk by Prof. Brian Hutton (UCL) on 22 October – (#1078) “Design of an ultra-low-dose, stationary, tomographic Molecular Breast Imaging system”
MIC mini-oral talk by Dr. Kjell Erlandsson (UCL) on 20 October – (#1021) “Challenges in optimization of a stationary tomographic Molecular Breast Imaging system

dougmachin
07/10/2021
13:45
Website update on the ground break breast cancer detection technology. Exciting stuff .
strategicinvestor2
05/10/2021
16:55
Again. A bit of ‘old news’ that’s been discussed on here or the lse board gets a bit of media attention and share price reacts with a ridiculous 7.88% increase.

How long before the same happens with the biological pathogen detectors? The story will get regurgitated, people will react with “what seriously, a device that could prevent the next pandemic spreading through air travel? And it can do a load of other things like identify unknown pathogens/future pandemics in society... and protect against biological attacks? The U.S government has been funding this company and they’ve completed the second round of funding? Plus it’s a company with various other leading products in hospital scanners, radiation and security detection thrown in for free? The whole lot is valued at a fraction of just the rival hospital scanner business that just sold last month?” Then there will hopefully be the boom we’ve all been waiting for

aqc888
05/10/2021
15:36
If Kromek is the only independent left in this field do people think a take over is possible and in what timeframe ?
strategicinvestor2
05/10/2021
14:03
Regarding my earlier post of “magazine snippets” and “YouTube blah, blah” That’s a great find, AQC. It really is about time that this has been quoted by multimedia and news providers now let’s hope this encourages investors and gets that share price north bound.
b00mb0y
05/10/2021
13:46
Dec 1999, FTSE 100 was 6724. Now it's 7052.

That's a whopping 4.87% interest over 21/22 years.

Agree, UK stock market has to be massively undervalued.

dougmachin
05/10/2021
13:36
Like a lot of quality UK companies, it's chronically undervalued. This will change, may take time but as as investors, worldwide seek greater value, the UK is one of the few markets left with massive headroom for growth.
dexter1612
05/10/2021
12:30
Broker today fair value in excess of 50p - and the rest !! Won’t be at these levels for long IMHO
strategicinvestor2
04/10/2021
16:05
If this share price don’t breakout of this all-time down trend by end of this month then it’s probably never going to.
b00mb0y
03/10/2021
21:30
I’m holding on till I have the result to the reason I invested.

They’re not out of the time guidance they’ve given - despite the CEO insisting things will happen sooner - only to disappoint.

Patience, patience, patience. They’ve already obtained orders for 80% of this financial year’s forecasts. Imagine what the commercialisation of the biological pathogen detectors would do to those forecasts and the share price. If they sold 500 globally that would double the annual turnover... big potential on offer here.

aqc888
03/10/2021
20:20
hxxps://www.thetimes.co.uk/article/missing-in-action-an-industrial-strategy-to-point-britains-way-02ch6bd2z

Kromek in today's Sunday Times.

I must admit to have sold some earlier in the week to top-up my holdings in speculative N4p & Star which especially the former looked too tempting, below 8p(seemed I was lucky with the timing re Friday's positive news- sorry for o/ t)
The delays on updates are so so frustrating, as we've all mentioned before.
Any news of substance and I'll be adding.

davethechef
03/10/2021
17:53
Soz,Aqc. But your posts are simply hopeful gestures. Just like most rampers on here now your clinging on to hopeful expectations. I am clinging on to be honest. I truly hope w have a rise soon, at least to breakeven. Let’s hope so.
b00mb0y
03/10/2021
17:38
When and if positive news comes in regard to the pathogen detectors, expect Simon Thompson to immediately write an update in the IC. This is almost guaranteed to happen as Kromek is one of his favourites and on his ‘strong buy’ list. So whatever share price gain you see at the time of the results - this will be amplified pretty quickly by Simon Thompson.
aqc888
03/10/2021
17:17
I share the frustration. The ceo keeps hinting a big unveiling is about to happen which really irritates most here when it fails to materialise. If you ignore him and just read the annual report in the RNS above you’ll probably be less frustrated. It would seem to me that the covid specific pathogen detector will be available for sale in 1-3months. Then the really interesting biological pathogen detector should be available by April as the CFO mentioned. All these share price movements before any release are completely futile up till then. We’ve seen 21-28p on excitement about Kromeks prospects and 11-15p at despair nothing will happen and losses will continue. 15-20p seems a fair price right now until Kromek proves it’s worth with a real scientific breakthrough with the pathogen detectors. Since Kromek has been extremely active in its patents at the moment (see my previous post where Kromek features in 4th place in an Intellectual Property league table for the year. Plus promethiums post on lse today). This activity Kromek has had around patents in the last year should provide some confidence and support to Kromeks claims.
aqc888
03/10/2021
04:07
Although i'm invested have to agree with B00mb0y. Don't want to see anymore Youtube videos i want to hear via official RNS what is actually going on right now!
ark87
02/10/2021
18:24
So what. Don’t seem like anyone bothered anymore. Your ramping is totally based on magazine snippets and YouTube blah blah. Investors are only interested in the share price rising. That’s not happening here! Until it does, give it a rest, mick33.
b00mb0y
02/10/2021
17:41
Interesting FT article from a couple of weeks ago.

Bioterror: the dangers of garage scientists manipulating DNA

"These garage scientists might seem like a quirky new subculture but their rogue mindset is starting to generate consternation among those who specialise in managing biological threats in governments and international bodies.

In 2018 the states that are signatories to the 1972 Biological Weapons Convention (BWC) identified gene editing, gene synthesis, gene drives and metabolic pathway engineering as research that qualifies as “dual use”, meaning it is as easy to deploy for harmful purposes as it is for good.

Many of the parties are now worried that increased accessibility to such technologies could heighten accidental or deliberate misuse, including the development of biological weapons by rogue actors for mass or targeted attacks.

33mick
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older

Your Recent History

Delayed Upgrade Clock